Frankfurt - Delayed Quote • EUR
X4 Pharmaceuticals, Inc. (48Q.F)
At close: April 26 at 8:04 AM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 7 | 8 |
| Avg. Estimate | -0.72 | -0.71 | -3.12 | -2.77 |
| Low Estimate | -0.82 | -0.95 | -3.88 | -3.94 |
| High Estimate | -0.53 | -0.47 | -2.56 | -2.22 |
| Year Ago EPS | -0.87 | -0.91 | -3.09 | -3.12 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | 590k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 3.41M |
| Year Ago Sales | -- | -- | 3M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2020 | 12/31/2020 | 3/31/2021 | 6/30/2021 |
|---|---|---|---|---|
| EPS Est. | -0.76 | -0.9 | -0.86 | -0.74 |
| EPS Actual | -0.87 | -0.91 | -1.3 | -0.74 |
| Difference | -0.11 | -0.01 | -0.44 | 0 |
| Surprise % | -14.50% | -1.10% | -51.20% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | -0.72 | -0.71 | -3.12 | -2.77 |
| 7 Days Ago | -0.72 | -0.71 | -3.12 | -2.77 |
| 30 Days Ago | -0.72 | -0.71 | -3.12 | -2.77 |
| 60 Days Ago | -0.76 | -0.74 | -3.15 | -2.86 |
| 90 Days Ago | -0.77 | -0.73 | -3.05 | -2.84 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | 48Q.F | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 17.20% | -- | -- | 6.50% |
| Next Qtr. | 22.00% | -- | -- | 12.00% |
| Current Year | -1.00% | -- | -- | 5.30% |
| Next Year | 11.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/22/2024 |
| Downgrade | B. Riley Securities: Buy to Neutral | 12/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/11/2023 |
| Maintains | Stifel: Buy to Buy | 5/17/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 5/5/2023 |
| Maintains | B. Riley Securities: Buy | 4/10/2023 |